Quick Answer
ASP Isotopes Inc. reported Operating Income Loss of -$26.35 million for the year ending 2024.
- ASP Isotopes Inc. showed a decrease of -64.3% in Operating Income Loss from 2023 to 2024.
- This data is from ASP Isotopes Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2022 to 2024 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2021: -$508.2 thousand | Q4 2021: -$2.61 million | Q1 2022: -$858.3 thousand | Q2 2022: -$828.0 thousand | Q3 2022: -$1.95 million | Q1 2023: -$3.72 million | Q2 2023: -$4.35 million | Q3 2023: -$3.95 million | Q1 2024: -$5.81 million | Q2 2024: -$7.46 million | Q3 2024: -$5.43 million | Q1 2025: -$7.95 million | Q2 2025: -$11.97 million | Q3 2025: -$14.97 million.
- Over the full 3 years of available data (2022 to 2024), ASP Isotopes Inc.'s Operating Income Loss has declined by 416.8%.
- Historical annual values: Fiscal year 2024: -$26.35 million | Fiscal year 2023: -$16.04 million | Fiscal year 2022: -$5.10 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: